Skip to main content
Journal cover image

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction.

Publication ,  Journal Article
Luo, N; O'Connor, CM; Chiswell, K; Anstrom, KJ; Newby, LK; Mentz, RJ
Published in: CJC Open
November 2021

BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well characterized for HF without CHD. We investigated the characteristics and 5-year mortality outcomes among patients with HF without significant CHD, stratified by EF. METHODS: Patients with clinical heart failure who underwent coronary angiography at Duke University Medical Center from 1996 through 2009 and had no significant CHD with EF ≤ 40% were compared with patients without significant CHD with EF > 40%. Survival was examined using Kaplan-Meier methods and multivariable Cox proportional hazards modeling. Analyses were repeated using EF ≥ 50%. RESULTS: Of 3154 patients with HF without significant CHD, 1530 (48.5%) had HFpEF (EF > 40%). These patients were older and more likely to have a Charlson Index ≥ 2 than patients with reduced EF. Patients with HFpEF had a lower risk of death than those with reduced EF (unadjusted hazard ratio [HR] 0.85; 95% confidence interval [CI] 0.74-0.99). From 1996 through 2009, the secular trend of death decreased among patients without CHD and with reduced EF (HR 0.92; 95% CI 0.88-0.97) but not among those with preserved EF (HR 0.99; 95% CI 0.93-1.05; P interaction 0.095). No finding was significant after multivariable risk adjustment. Results were consistent when defining preserved EF as EF ≥ 50%. CONCLUSIONS: Among patients without significant CHD, those with HFpEF had similar risks of 5-year mortality as patients with HF with reduced ejection fraction.

Duke Scholars

Published In

CJC Open

DOI

EISSN

2589-790X

Publication Date

November 2021

Volume

3

Issue

11

Start / End Page

1333 / 1340

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luo, N., O’Connor, C. M., Chiswell, K., Anstrom, K. J., Newby, L. K., & Mentz, R. J. (2021). Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction. CJC Open, 3(11), 1333–1340. https://doi.org/10.1016/j.cjco.2021.06.007
Luo, Nancy, Christopher M. O’Connor, Karen Chiswell, Kevin J. Anstrom, L Kristin Newby, and Robert J. Mentz. “Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction.CJC Open 3, no. 11 (November 2021): 1333–40. https://doi.org/10.1016/j.cjco.2021.06.007.
Luo N, O’Connor CM, Chiswell K, Anstrom KJ, Newby LK, Mentz RJ. Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction. CJC Open. 2021 Nov;3(11):1333–40.
Luo, Nancy, et al. “Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction.CJC Open, vol. 3, no. 11, Nov. 2021, pp. 1333–40. Pubmed, doi:10.1016/j.cjco.2021.06.007.
Luo N, O’Connor CM, Chiswell K, Anstrom KJ, Newby LK, Mentz RJ. Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction. CJC Open. 2021 Nov;3(11):1333–1340.
Journal cover image

Published In

CJC Open

DOI

EISSN

2589-790X

Publication Date

November 2021

Volume

3

Issue

11

Start / End Page

1333 / 1340

Location

United States